Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers

Bernadette A. M. Heemskerk-Gerritsen*, Agnes Jager, Linetta B. Koppert, A. Inge-Marie Obdeijn, Margriet Collee, Hanne E. J. Meijers-Heijboer, Denise J. Jenner, Hester S. A. Oldenburg, Klaartje van Engelen, Jakob de Vries, Christi J. van Asperen, Peter Devilee, Marinus J. Blok, C. Marleen Kets, Margreet G. E. M. Ausems, Caroline Seynaeve, Matti A. Rookus, Maartje J. Hooning

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)723-733
Number of pages11
JournalBreast Cancer Research and Treatment
Volume177
Issue number3
DOIs
Publication statusPublished - Oct 2019

Keywords

  • BRCA1
  • 2
  • Bilateral risk-reducing mastectomy
  • Prevention
  • Surveillance
  • Survival
  • CONTRALATERAL BREAST-CANCER
  • OVARIAN-CANCER
  • PROPHYLACTIC MASTECTOMY
  • SURGERY
  • STRATEGIES
  • EFFICACY
  • FAMILIES
  • SERIES
  • WOMEN
  • TIME

Cite this

Heemskerk-Gerritsen, B. A. M., Jager, A., Koppert, L. B., Obdeijn, A. I-M., Collee, M., Meijers-Heijboer, H. E. J., Jenner, D. J., Oldenburg, H. S. A., van Engelen, K., de Vries, J., van Asperen, C. J., Devilee, P., Blok, M. J., Kets, C. M., Ausems, M. G. E. M., Seynaeve, C., Rookus, M. A., & Hooning, M. J. (2019). Survival after bilateral risk-reducing mastectomy in healthy BRCA1 and BRCA2 mutation carriers. Breast Cancer Research and Treatment, 177(3), 723-733. https://doi.org/10.1007/s10549-019-05345-2